Mutations known from B-cell lymphoid malignancies are not found in CD34
+
stem cells from patients with lymphoma
Leuk Lymphoma
.
2021 Nov;62(11):2808-2811.
doi: 10.1080/10428194.2021.1933473.
Epub 2021 Jun 21.
Authors
Simon Husby
1
2
3
,
Francesco Favero
2
4
,
Francisco G Rodriguez-Gonzalez
2
4
,
Lesley A Sutton
5
,
Eva K Haastrup
6
,
Andreas Due Ørskov
1
2
,
Jakob W Hansen
1
2
3
,
Bente Arboe
2
,
Derya Aslan
1
2
,
Erik Clasen-Linde
7
,
Lise Mette Rahbek Gjerdrum
8
,
Jette Sønderskov Gørlev
1
,
Peter Brown
1
,
Anne Fischer-Nielsen
6
,
Richard Rosenquist
5
,
Joachim Weischenfeldt
2
4
,
Kirsten Grønbæk
1
2
3
Affiliations
1
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
2
Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
3
Faculty of Health Sciences, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen, Copenhagen, Denmark.
4
Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.
5
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
6
Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark.
7
Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
8
Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
PMID:
34151700
DOI:
10.1080/10428194.2021.1933473
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Antigens, CD34
B-Lymphocytes
Hematopoietic Stem Cell Mobilization
Humans
Lymphoma* / diagnosis
Lymphoma* / genetics
Lymphoma* / therapy
Mutation
Stem Cells
Substances
Antigens, CD34